Skip to main content
Erschienen in: Diabetologia 4/2012

01.04.2012 | Article

Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting

verfasst von: L. J. Gray, M. J. Davies, S. Hiles, N. A. Taub, D. R. Webb, B. T. Srinivasan, K. Khunti

Erschienen in: Diabetologia | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to develop and validate a score for detecting the glycaemic categories of impaired glucose regulation (IGR) and type 2 diabetes using the WHO 2011 diagnostic criteria.

Methods

We used data from 6,390 individuals aged 40–75 years from a multiethnic population based screening study. We developed a logistic regression model for predicting IGR and type 2 diabetes (diagnosed using OGTT or HbA1c ≥6.5% [48 mmol/mol]) from data which are routinely stored in primary care. We developed the score by summing the β coefficients. We externally validated the score using data from 3,225 participants aged 40–75 years screened as part of another study.

Results

The score includes age, ethnicity, sex, family history of diabetes, antihypertensive therapy and BMI. Fifty per cent of a population would need to be invited for testing to detect type 2 diabetes mellitus on OGTT with 80% sensitivity; this is slightly raised to 54% that need to be invited if using HbA1c. Inviting the top 10% for testing, 9% of these would have type 2 diabetes mellitus using an OGTT (positive predictive value [PPV] 8.9% [95% CI 5.8%,12.8%]), 26% would have IGR (PPV 25.9% [95% CI 20.9%, 31.4%]). Using HbA1c increases the PPV to 19% for type 2 diabetes mellitus (PPV 18.6% [95% CI 14.2%, 23.7%]) and 28% for an HbA1c between 6.0% and 6.4% (PPV 28.3% [95% CI 23.1%, 34.0%]).

Conclusions

The score can be used to reliably identify those with undiagnosed IGR and type 2 diabetes in multiethnic populations. This is the first score developed taking into account HbA1c in the diagnosis of type 2 diabetes.
Literatur
2.
Zurück zum Zitat Chatterjee R, Narayan KMV, Lipscombe J, Phillips LS (2010) Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 33:1484–1490PubMedCrossRef Chatterjee R, Narayan KMV, Lipscombe J, Phillips LS (2010) Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care 33:1484–1490PubMedCrossRef
3.
Zurück zum Zitat Paddison CAM, Eborall HC, French DP et al (2011) Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol 16:213–226PubMedCrossRef Paddison CAM, Eborall HC, French DP et al (2011) Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol 16:213–226PubMedCrossRef
4.
Zurück zum Zitat Griffin SJ, Borch-Johnsen K, Davies MJ et al (2011) Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378:156–167PubMedCrossRef Griffin SJ, Borch-Johnsen K, Davies MJ et al (2011) Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378:156–167PubMedCrossRef
5.
Zurück zum Zitat Kahn R, Alperin P, Eddy D et al (2010) Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 375:1365–1374PubMedCrossRef Kahn R, Alperin P, Eddy D et al (2010) Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 375:1365–1374PubMedCrossRef
6.
Zurück zum Zitat Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334. doi:10.1136/bmj.39063.689375.55 Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334. doi:10.​1136/​bmj.​39063.​689375.​55
7.
Zurück zum Zitat de Lusignan S, van Weel C (2006) The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 23:253–263PubMedCrossRef de Lusignan S, van Weel C (2006) The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 23:253–263PubMedCrossRef
8.
Zurück zum Zitat Walker N, Gardiner E, Davies M, Khunti K (2009) The NHS Health Checks programme – Implications for delivery in primary care. Diabetes Primary Care 11:209–215 Walker N, Gardiner E, Davies M, Khunti K (2009) The NHS Health Checks programme – Implications for delivery in primary care. Diabetes Primary Care 11:209–215
9.
Zurück zum Zitat World Health Organisation (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Report. Geneva: World Health Organisation World Health Organisation (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Report. Geneva: World Health Organisation
10.
Zurück zum Zitat World Health Organisation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO, Geneva World Health Organisation (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO, Geneva
11.
Zurück zum Zitat International Expert Committee (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32:1327e34CrossRef International Expert Committee (2009) International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32:1327e34CrossRef
12.
Zurück zum Zitat Gray LJ, Taub N, Khunti K et al (2010) The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27:887–895PubMedCrossRef Gray LJ, Taub N, Khunti K et al (2010) The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27:887–895PubMedCrossRef
13.
Zurück zum Zitat Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef
14.
Zurück zum Zitat Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. Br Med J 388:b880CrossRef Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. Br Med J 388:b880CrossRef
15.
Zurück zum Zitat Webb D, Khunti K, Srinivasan B et al (2010) Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 19:16CrossRef Webb D, Khunti K, Srinivasan B et al (2010) Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 19:16CrossRef
16.
17.
Zurück zum Zitat Akaike H (1974) A new look at the statistical model identification. IEEE Trans Auto Control 19:716–723CrossRef Akaike H (1974) A new look at the statistical model identification. IEEE Trans Auto Control 19:716–723CrossRef
18.
Zurück zum Zitat Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkCrossRef Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New YorkCrossRef
19.
Zurück zum Zitat Gray LJ, Tringham J, Davies MJ et al (2010) Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. J Vasc Health Risk Manage 6:837–842CrossRef Gray LJ, Tringham J, Davies MJ et al (2010) Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. J Vasc Health Risk Manage 6:837–842CrossRef
20.
Zurück zum Zitat Thomas C, Hypponen E, Power C (2006) Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 166:682–688PubMedCrossRef Thomas C, Hypponen E, Power C (2006) Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 166:682–688PubMedCrossRef
21.
Zurück zum Zitat Schwarz PEH, Li J, Relmann M et al (2009) The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab 94:920–926PubMedCrossRef Schwarz PEH, Li J, Relmann M et al (2009) The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. J Clin Endocrinol Metab 94:920–926PubMedCrossRef
22.
Zurück zum Zitat Mostafa SA, Davies MJ, Webb D et al (2010) The potential impact of using glycated haemoglobin, HbA1c, as the preferred diagnostic tool for type 2 diabetes mellitus. Diabet Med 72:762–769CrossRef Mostafa SA, Davies MJ, Webb D et al (2010) The potential impact of using glycated haemoglobin, HbA1c, as the preferred diagnostic tool for type 2 diabetes mellitus. Diabet Med 72:762–769CrossRef
23.
Zurück zum Zitat Spijkerman AMW, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ (2004) The Performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups. Data from the 1999 Health Survey for England. Diabetes Care 27:116–122PubMedCrossRef Spijkerman AMW, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ (2004) The Performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups. Data from the 1999 Health Survey for England. Diabetes Care 27:116–122PubMedCrossRef
24.
Zurück zum Zitat Goldby S, Gray LJ, Khunti K et al (eds) (2011) Using the Leicester practice risk score to identify people with diabetes and impaired glucose regulation (Abstract). Diabetes UK; London Goldby S, Gray LJ, Khunti K et al (eds) (2011) Using the Leicester practice risk score to identify people with diabetes and impaired glucose regulation (Abstract). Diabetes UK; London
25.
Zurück zum Zitat Henson J, Gray LJ, Yates T et al (eds) (2011) Using the Leicester practice risk score to identify people with diabetes and impaired glucose regulation: data from the walking away from diabetes CLAHRC study. HSRN/SDO Network Joint Conference, Liverpool Henson J, Gray LJ, Yates T et al (eds) (2011) Using the Leicester practice risk score to identify people with diabetes and impaired glucose regulation: data from the walking away from diabetes CLAHRC study. HSRN/SDO Network Joint Conference, Liverpool
26.
Zurück zum Zitat Khunti K, Taub N, Gillies C et al (2009) A comparison of screening strategies for impaired glucose tolerance and type 2 diabetes mellitus in a UK community setting: a cost per case analysis (Abstract) 45th EASD Annual Meeting, Vienna. Diabetologia 52(Suppl 1):283 Khunti K, Taub N, Gillies C et al (2009) A comparison of screening strategies for impaired glucose tolerance and type 2 diabetes mellitus in a UK community setting: a cost per case analysis (Abstract) 45th EASD Annual Meeting, Vienna. Diabetologia 52(Suppl 1):283
27.
Zurück zum Zitat Aujla N, Eborall H, Stone M, Taub N, Davies M, Khunti K (2010) Barriers to practice and patient recruitment to primary care based diabetes screening. Diabetic Med 27(Suppl 1):S371 Aujla N, Eborall H, Stone M, Taub N, Davies M, Khunti K (2010) Barriers to practice and patient recruitment to primary care based diabetes screening. Diabetic Med 27(Suppl 1):S371
28.
Zurück zum Zitat Webb DR, Gray LJ, Khunti K et al (2011) Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54:2237–2246PubMedCrossRef Webb DR, Gray LJ, Khunti K et al (2011) Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54:2237–2246PubMedCrossRef
29.
Zurück zum Zitat Gholap N, Davies MJ, Patel K, Sattar N, Khunti K (2011) Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 5:45–56PubMedCrossRef Gholap N, Davies MJ, Patel K, Sattar N, Khunti K (2011) Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 5:45–56PubMedCrossRef
Metadaten
Titel
Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting
verfasst von
L. J. Gray
M. J. Davies
S. Hiles
N. A. Taub
D. R. Webb
B. T. Srinivasan
K. Khunti
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2432-x

Weitere Artikel der Ausgabe 4/2012

Diabetologia 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.